We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
-1.19%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$1.56B
AUM Growth
-$29.8M
Cap. Flow
-$341K
Cap. Flow %
-0.02%
Top 10 Hldgs %
25.81%
Holding
3,122
New
704
Increased
853
Reduced
892
Closed
464

Sector Composition

Rank Sector Weight
1 Technology 5.41%
2 Financials 3.2%
3 Healthcare 2.44%
4 Consumer Discretionary 2.3%
5 Industrials 1.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCYT icon
2301
Veracyte
VCYT
$3.71B
$1.01K ﹤0.01%
34
+17
+100% +$648
LKFT
2302
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.71B
$1K ﹤0.01%
40
BBW icon
2303
Build-A-Bear
BBW
$435M
$1K ﹤0.01%
+27
New +$1.07K
XSD icon
2304
State Street SPDR S&P Semiconductor ETF
XSD
$2.9B
$1K ﹤0.01%
+5
New +$1.19K
MQ icon
2305
Marqeta
MQ
$1.74B
$1K ﹤0.01%
+61
New +$962
UIS icon
2306
Unisys
UIS
$210M
$997 ﹤0.01%
217
+121
+126% +$675
MTH icon
2307
Meritage Homes
MTH
$4.71B
$993 ﹤0.01%
14
-22
-61% -$1.65K
BBT
2308
Beacon Financial Corp
BBT
$2.67B
$992 ﹤0.01%
38
ENLV icon
2309
Enlivex Ltd
ENLV
$33.3M
$985 ﹤0.01%
68
WNS
2310
DELISTED
WNS Holdings
WNS
$984 ﹤0.01%
+16
New +$913
COCO icon
2311
Vita Coco
COCO
$3.71B
$981 ﹤0.01%
32
-91
-74% -$3.25K
BRZE icon
2312
Braze
BRZE
$2.9B
$975 ﹤0.01%
+27
New +$1.09K
APGE icon
2313
Apogee Therapeutics
APGE
$10.2B
$972 ﹤0.01%
+26
New +$1K
SWTX
2314
DELISTED
SpringWorks Therapeutics
SWTX
$972 ﹤0.01%
22
-45
-67% -$2.07K
IOO icon
2315
iShares Global 100 ETF
IOO
$9.19B
$963 ﹤0.01%
+10
New +$1.01K
HAE icon
2316
Haemonetics
HAE
$3.87B
$954 ﹤0.01%
15
+6
+67% +$408
LBRT icon
2317
Liberty Energy
LBRT
$3.27B
$950 ﹤0.01%
60
-1,438
-96% -$25.8K
OOMA icon
2318
Ooma
OOMA
$588M
$943 ﹤0.01%
+72
New +$1.02K
SFL icon
2319
SFL Corp
SFL
$1.61B
$943 ﹤0.01%
+115
New +$1.11K
TBCH
2320
Turtle Beach Corp
TBCH
$249M
$942 ﹤0.01%
+66
New +$1.1K
BZH icon
2321
Beazer Homes USA
BZH
$915M
$938 ﹤0.01%
+46
New +$1.1K
MCBS icon
2322
MetroCity Bankshares
MCBS
$1.03B
$938 ﹤0.01%
34
-341
-91% -$10.2K
MEI icon
2323
Methode Electronics
MEI
$585M
$938 ﹤0.01%
+147
New +$1.45K
WLY icon
2324
John Wiley & Sons Class A
WLY
$2.72B
$936 ﹤0.01%
21
-117
-85% -$4.94K
AORT icon
2325
Artivion
AORT
$1.29B
$935 ﹤0.01%
38
+19
+100% +$528

Similar funds

Arax Advisory Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Arax Advisory Partners held 3,122 positions worth $1.56B, down 1.9% from $1.59B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Arax Advisory Partners's Q1 2025 filing shows 704 new, 853 increased, 892 reduced and 464 closed positions. Its largest new stake was Avantis Core Fixed Income ETF: 645,396 shares worth $26.7M. The largest sale was Dimensional Core Fixed Income ETF, an estimated $25.2M.

By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 5.9% a quarter earlier, followed by Financials and Healthcare.

  • Arax Advisory Partners's largest Q1 2025 buy was Avantis Core Fixed Income ETF: 645,396 shares worth $26.7M.
  • Arax Advisory Partners added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2025, an estimated $21.8M increase.
  • Arax Advisory Partners's biggest Q1 2025 reduction was Dimensional Core Fixed Income ETF, cutting an estimated $25.2M.
  • Arax Advisory Partners fully exited Berkshire Hathaway Class B in Q1 2025, selling an estimated $1.03M.
  • Arax Advisory Partners's ten largest holdings make up 26% of its $1.56B portfolio in Q1 2025.
  • Arax Advisory Partners opened 704 new positions and closed 464 in Q1 2025.
  • Arax Advisory Partners's portfolio value fell 1.9% quarter-over-quarter to $1.56B.

Based on Arax Advisory Partners's 13F filing for Q1 2025, filed 15 May 2025.